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ABSTRACT: 
The ongoing outbreak of the novel coronavirus disease (COVID-19) has spread globally and 
poses a threat to public health in more than 140 countries. Reliable laboratory diagnosis of the 
disease has been one of the foremost priorities for promoting public health interventions. The 
routinely used reverse transcription polymerase chain reaction (RT-PCR) is currently the 
reference method for COVID-19 diagnosis. However, it also reported a number of false-
positive or -negative cases, especially in the early stages of the novel virus outbreak. In this 
work, a dual-functional plasmonic biosensor combining the plasmonic photothermal (PPT) 
effect and localized surface plasmon resonance (LSPR) sensing transduction provides an 
alternative and promising solution for the clinical COVID-19 diagnosis. The two-dimensional 
gold nanoislands (AuNIs) functionalized with complementary DNA receptors can perform a 
sensitive detection of the selected sequences from severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) through nucleic acid hybridization. For better sensing 
performance, the thermoplasmonic heat is generated on the same AuNIs chip when illuminated 
at their plasmonic resonance frequency. The localized PPT heat is capable to elevate the in situ 
hybridization temperature and facilitate the accurate discrimination of two similar gene 
sequences. Our dual-functional LSPR biosensor exhibits a high sensitivity toward the selected 
SARS-CoV-2 sequences with the lower detection limit down to the concentration of 0.22 pM 
and allows precise detection of the specific target in a multi-gene mixture. This study gains 
insight into the thermoplasmonic enhancement and its applicability in the nucleic acid tests and 
viral disease diagnosis. 
KEYWORDS: plasmonic photothermal effect, severe acute respiratory syndrome coronavirus 
2, coronavirus disease, LSPR, biosensors, nuclei acids, RNA virus  
 
At the end of 2019, the first case of pneumonia of unknown origin was detected in 
Wuhan, China.1 High-throughput sequencing revealed that this was a new severe acute 
respiratory syndrome beta-coronavirus (SARS-CoV-2), and a novel coronavirus disease 
(COVID-19).2 Up to 1 April 2020, the rapid spread of COVID-19 has impacted more than 200 
countries with more than 900,000 laboratory-confirmed cases and 45,000 deaths (with high 
numbers in China, United States, Spain and Italy).3, 4 COVID-19 is the third large-scale 
pandemic caused by coronavirus in the last two decades after severe acute respiratory 
syndrome (SARS) in 2003 and Middle East Respiratory Syndrome (MERS) in 2012.5, 6 These 
two coronaviruses have caused about 10,000 cumulative cases, with mortality rates of 10% for 
SARS-CoV and 37% for MERS-CoV. Regarding the SARS-CoV-2, the laboratory-confirmed 
COVID-19 cases have already been more than ninety times higher than the total confirmed 
cases of SARS and MERS.7 There is no-doubt that fast and accurate identification of a novel 
virus can greatly contribute to the control of an emerging pandemic. 
Reliable laboratory diagnosis has been one of the foremost priorities for promoting 
epidemic prevention and control. In acute respiratory infection, the molecular method reverse 
transcription polymerase chain reaction (RT-PCR) is routinely used to detect causative viruses 
using samples from respiratory secretions.8 According to the latest version of “WHO interim 
guidance for laboratory testing for COVID-19 in humans”, several molecular assays that detect 
the COVID-19 have been developed.9 The gene targets for RT-PCR molecular assays selected 
by different countries are genetically similar, including the RNA-dependent RNA polymerase 
(RdRp) sequence and the open reading frame 1ab (ORF1ab) sequence. Generally, RT-PCR is 
currently the most sensitive method of viral RNA detection by rapidly making many copies of 
a specific sequence. The sensitivity of a recent SARS-CoV-2 study has reached 3.7 RNA copies 
on detecting RdRp sequence.8 However, RT-PCR can also fail for various reasons, such as its 
amplification of spurious nucleic acid contaminations. The RT-PCR assays for SARS-CoV-2 
detection have reported a number of false-negative results on confirmed infection cases.10 In 
clinical diagnosis, a single negative PCR result does not rule out COVID-19 infection as the 
reported positive rate was only 30-50% for laboratory-confirmed COVID-19 cases at the early 
stage of the outbreak.11 Particularly if the sample is from an upper respiratory tract (URT) 
specimen. A recent study of 167 COVID-19 infection patients showed that 5 (3%) patients had 
positive chest computed tomography (CT) findings but false-negative results from the RT-PCR 
testing. These 5 patients were eventually confirmed with COVID-19 infection by repeated 
swab tests.10 In addition, the current RT-PCR-based detection methods demand high manpower 
and long processing time, which may not be able to provide the capacity to test all the suspected 
cases during full-scale outbreaks. Other approaches such as CT scan and culture methods are 
apparently not suitable for fast-response detection and real-time analysis.12 Therefore, it is 
advantageous to thoroughly investigate suspected patients by another reliable diagnosis 
system.  
Biosensors are ideal to provide an alternative and reliable solution to the clinical 
diagnosis, real-time detection and continuous monitoring.13, 14 Among the different biosensing 
techniques, localized surface plasmon resonance (LSPR) biosensing systems are applicable to 
different classes of analytes of clinical interests.15 LSPR is a strong photon-driven coherent 
oscillation of the surface conduction electrons, which can be modulated when coupling occurs 
at the surface of the plasmonic materials.16 Owing to the enhanced plasmonic field in the 
vicinity of the nanostructures, LSPR sensing systems demonstrate high sensitivity to local 
variation, including the refractive index change and molecular binding.17 Thus, LSPR is an 
ideal candidate for real-time and label-free detection of micro- and nano-scale analytes.18, 19 A 
latest research has utilized SPR to test the biophysical properties of SARS-CoV-2 spike protein 
and found that the SARS-CoV-2 spike glycoprotein bound angiotensin-converting enzyme 2 
(ACE2) with much higher affinity than SARS-CoV spike protein.20 In addition, several SARS-
CoV receptor-binding domains (RBDs)-specific monoclinal antibodies were also tested in this 
study and demonstrated that these antibodies did not have appreciable binding to the spike 
protein of SARS-CoV-2. The key property of nucleic acids that renders them so useful for 
clinical diagnosis, therapy and bio-nanotechnology is the predictable and specific hybridization 
of complementary bases.21 Thus, the LSPR technique for genetic testing and nucleic acid 
detection in clinical practices could be an interesting alternative for SARS-CoV-2 detection 
and COVID-19 diagnosis.  
The novel SARS-CoV-2 virus is a positive sense, single-stranded RNA virus. The 
DNA-RNA hybridization has been widely used in RT-PCR as well as various biomedical 
sensors. The criteria for hybridization are based on nucleic acid strand melting.22, 23 Two 
complementary strands can specifically hybridize with each other when the temperature is 
slightly lower than their melting temperature, while a single mismatch can cause the melting 
temperature to decrease significantly.24 It is worth noting that the plasmonic nanoparticles 
normally exhibit large optical cross-sections and the absorbed light can be nonradiatively 
relaxed resulting in a significant heating energy.25, 26 The converted plasmonic photothermal 
(PPT) heat energy, also known as the thermoplasmonic effect is highly localized near the 
nanoparticles, which can be used as a stable in situ heat source for controllable and uniform 
thermal processing.26-29 In this work, we developed a dual-functional LSPR biosensor through 
combining the photothermal effect and plasmonic sensing transduction for SARS-CoV-2 viral 
nucleic acid detection. The plasmonic chip with the two-dimensional distribution of 
nanoabsorbers (AuNIs) is capable to generate the local PPT heat and transduce the in situ 
hybridization for highly sensitive and accurate SARS-CoV-2 detection. 
 
Figure 1. Experimental setup and system optimization. (a) Schematic and (b) experimental 
setup of the dual-functional PPT enhanced LSPR biosensing system. In the LSPR sensing path, 
the collimated wide spectrum beam passed through the aperture-iris (I1/I2), the linear 
polarizers (P1/P2), the birefringent crystal (BC), and totally reflected at the interface of AuNIs-
dielectric for LSPR detection. In the excitation unit, a laser diode (LD) was used to generate 
the PPT effect on AuNIs in the normal incident angle. (c) and (d) demonstrated the normalized 
absorbances of the AuNIs sensor chips showing a fine-tune peak absorption from 523.4 nm to 
539.7 nm (± 0.2 nm). (e) Plasmonic resonance wavelength at about 580 nm under the ATR 
(attenuated total reflection) configuration for LSPR sensing transduction. 
RESULTS AND DISCUSSION 
The dual-functional plasmonic performances were systematically studied in the aspects 
of LSPR sensing transduction and PPT heating. The common-path differential phase-sensitive 
LSPR system, as shown in Figure 1a, was adopted to measure the local refractive index 
changes or the binding events. In the LSPR sensing transduction unit, the sensing beam was 
generated by a wide spectrum LED source and operated in the ATR (attenuated total reflection) 
mode at the interface between the glass substrate and liquid environment. When reaching the 
two-dimensional AuNIs sensing layer, the measured optical power of the beam was found to 
be 32.58 𝜇𝑊 . The local plasmonic responses were retrieved from the ATR spectral 
interferograms by using the windowed Fourier transform phase extraction method, as described 
elsewhere.30 This phase response, reported in the unit of radian, is more prominent than the 
conventional spectral and angular responses. Therefore, it has been utilized for improving the 
sensitivity of plasmonic sensors.31 In order to generate a stable and intense thermoplasmonic 
field, an excitation laser with 532 nm peak wavelength and 40 mW maximum optical power 
was applied onto the AuNIs chip in the normal incident angle (Figure 1b). In addition, 
optimizing the AuNIs chip so that its peak absorbance wavelength was exactly at 532 nm can 
significantly improve the conversion efficiency of thermoplasmonic. By adjusting the Au 
nanofilm thickness before dewetting, the absorption peak (under normal incident angle) can be 
accurately controlled within a wavelength range from 523.4 nm to 539.7 nm as shown in 
Figure 1c, 1d, and Figure S1. In this work, the AuNIs that matched the laser excitation 
wavelength at 532.2 nm (± 0.2 nm) were utilized for the PPT heating.32 It is worth noting that 
under the ATR condition with a 72° inclined incident angle, the plasmonic resonance 
wavelength for LSPR sensing transduction red-shifted to 580 nm due to the prism coupling and 
the inclined angle of incidence (Figure 1e).30 The phase changes caused by a local variation of 
LSPR conditions were confined in a narrow wavelength region from 578 nm to 582 nm. 
Moreover, after adding a long-pass filter (LPF) with a cut-on wavelength at 552 nm, the 532 
nm photothermal excitation laser from the PPT unit did not influence the stability of the real-
time LSPR sensing transduction.  
In the thermoplasmonic testing, the direct absorption of laser irradiation at 532 nm 
decayed nonradiatively by generating more hot electrons in AuNIs.33 The photoexcited highly 
energetic electrons quickly dissipated and released thermal energies to heat the ambient 
environments. Conversely, the PPT induced temperature increase was also responsible for a 
refractive index variation of the surrounding environment, which can be in situ detected by the 
LSPR detection system as shown in Figure 2a. Specifically, the AuNIs chip was exposed to 
laser excitation for 50 s, as indicated by the shaded region.  Then the laser was switched off to 
re-attain the baseline. The generation and equilibrium of local photothermal heating were 
relatively fast. According to the laser switching tests as shown in Figure S2, the rapid heating 
process was completed within one second after turning on the laser excitation. Subsequently, 
the dynamic equilibrium process took another 11 s before finally entering the steady state. In 
our experiments, we calibrated the LSPR phase response under different ambient temperatures. 
The in situ temperature arising from the PPT effect was characterized based on the 
measurement of the thermal-induced refractive index variation in the vicinity of AuNIs.32, 34 
During the ambient temperature variation, the real-time LSPR phase responses and temperature 
values were recorded in parallel (Figure 2b), and the correlation was established as shown in 
Figure 2c. Based on this calibrated LSPR-temperature regression, the localized photothermal 
temperatures under different laser powers were retrieved as shown in Figure 2d.  
To further evaluate the laser induced PPT effect and the local temperature profile, we 
utilized the spectrometer to scan the heating area for mapping the LSPR phase responses and 
actual temperature distribution on the AuNIs sensor chips. In the experimental setup as shown 
in Figure S3, the excitation laser with 32 mW power was applied to the optimal AuNIs 
absorbers with a peak absorption at 532.2 nm (± 0.2 nm). At each point of interest, we used the 
LSPR transducing unit to record two interferometric spectra: one reference without PPT 
heating and one spectrum with PPT heating. By scanning the laser spot and surrounding area 
with a 0.5 mm step interval, the spatial distribution of LSPR phase changes was retrieved as 
shown in Figure 2e. At each scanning pixel, the retrieved phase response was subsequently 
converted to the local temperature based on the calibration curve in Figure 2c. Therefore, the 
corresponding temperature distribution around the PPT heating was obtained and illustrated in 
Figure 2f. The local temperature was significantly elevated from 21.47 °C (room temperature) 
to 41.08 °C at the center of the laser spot.  
 
Figure 2. In situ characterization of local PPT heating on AuNIs. (a) Periodic laser excitation 
and the PPT induced plasmonic phase response. (b) Temperature variations and real-time 
LSPR responses. (c) Calibration curve illustrating the relationship between the temperature and 
LSPR phase response. (d) Real-time LSPR responses caused by the laser induced PPT effect 
under different laser powers. (e) Scanned local LSPR responses around the PPT heat source on 
AuNIs. (d) Mapping the temperature distribution around the PPT heat source. 
 
We shall now present the sensing results of the SARS-CoV-2 by the proposed dual-
functional plasmonic biosensors. The full genome sequence data of the viruses, i.e. SARS-
CoV-2 and SARS-CoV, have been retrieved from the GISAID platform. The selected 
oligonucleotides for specific SARS-CoV-2 detection and their relative positions were given in 
Figure 3a and Table S1. These viral oligonucleotides refer to sequences used in different 
countries for COVID-19 diagnosis, and some of them have been published in the latest 
researches.8, 9, 35 The basic local alignment search tool (BLAST) was used to compare these 
viral sequences with the library of SARS-CoV-2 to confirm their representativeness and 
specificity. In the present case of COVID-19, SARS-CoV-2 isolates or samples from infected 
patients are challenging to obtain and handle. Thus, the corresponding DNA sequences were 
artificially synthesized for representative LSPR sensing demonstration of SARS-CoV-2 and 
SARS-CoV. According to the WHO guideline and local alignment searching results, two 
specific sequences from SARS-CoV-2 were selected, i.e. the RdRp and the ORF1ab as shown 
in Figure 3a. Validation and proof of selectivity were demonstrated by choosing the closely 
related nucleic acid sequence from RdRp of SARS-CoV. In addition, an oligonucleotide 
sequence from the coronaviral envelope protein gene (E) was also synthesized and tested to aid 
the virus identification.  
Based on the synthetic oligonucleotide receptors with a thiol group (Table S2), the 
LSPR sensing chips were directly functionalized by forming the Au-S bond between the thiol-
cDNA receptor and AuNIs as illustrated in Figure 3b. The surface functionalization process 
was initially optimized on its amount and concentration in order to achieve proper surface 
coverage and high sensitivity. During the real-time surface functionalization as shown in 
Figure 3c, step-by-step injections of 0.1 nmol thiol-cDNA of RdRp-COVID, (RdRp-COVID-
C) caused continuous phase jumps due to the covalent binding between AuNIs and thiol-cDNA. 
After a total immobilization of 1 nmol (10  0.1 nmol) RdRp-COVID-C as shown in Figure 
3c and 3d, the LSPR response stopped growing and indicated the appropriate amount of cDNA 
receptors for AuNIs functionalization. Hereafter, the solution containing 1 nmol thiol-cDNA 
was utilized to functionalize the AuNIs microfluidic sensor chips for SARS-CoV-2 sequences 
detection (Figure S4). The proper surface functionalization that is sufficient to functionalize 
the entire AuNIs sensing surface can increase the sensitivity and suppress the non-specific 
binding events.  In contrast, the AuNIs sensor chip was over-saturated when functionalized 
with 10 nmol cDNA, and insufficiently covered by using 0.1 nmol cDNA (Figure S5).  
 
Figure 3. Selected viral sequences for SARS-CoV-2 detection. (a) Selected sequences and their 
relative positions used for SARS-CoV-2 and SARS-CoV detection. M: membrane protein gene; 
N: nucleocapsid protein gene; S: spike protein gene. The numbers below sequences are genome 
positions according to GenBank, SARS-CoV-2 NC_045512. (b) Schematic illustration of 
AuNIs functionalization based on the reaction with thiol-cDNA ligands. (c). Real-time 
monitoring of AuNIs functionalization dynamics. 10 𝜇𝐿 solution containing 0.1 nmol cDNA 
was injected in each step. (d) Calibrated surface functionalization efficiency to retrieve the 
optimal cDNA amount. 
 
The surface functionalized AuNIs chips were subsequently installed in the LSPR 
systems for specific viral sequences detection (Figure 4a). The impacts of the localized 
thermoplasmonic heating on nucleic acids hybridization and LSPR detection were 
systematically studied. According to the temperature profile shown in Figure 2f, the excited 
PPT heat with approximately 41 °C nominal temperature was generated on the AuNIs sensor. 
Before the injection of RdRp sequence, nuclease-free water was flown across the microfluidic 
sensing chamber and the thermoplasmonic laser (32 mW) was turned on to establish a steady 
phase reference and baseline. According to the phase sensing diagram in Figure 4b and S6a, 
the LSPR response of the dual-functional AuNIs biosensor started to increase when the RdRp-
COVID genes were injected into the microfluidic chamber at about 200 s and attained the 
maximum phase value after about 800 s hybridization. The dual-functional AuNIs sensing chip 
was further flushed with the nuclease-free water to remove the non-specific binding items and 
to check the final LSPR phase response. In the comparison with and without the PPT effect, 
the hybridization rate and the LSPR sensing response level were obviously suppressed when 
the PPT unit was shut down as shown in Figure 4b. It proved that the localized photothermal 
effect can significantly improve the hybridization kinetics of the RdRp-COVID and its cDNA. 
Thus, the response-slope of the photothermal enhanced LSPR was much steeper than that 
without the photothermal assistance. Due to the faster hybridization kinetics, the differential 
phase response levels were also elevated for the RdRp-COVID sequence at different 
concentrations as shown in Figure 4c and Figure S6. The PPT effect and its derived local heat 
can effectively promote the fast and sensitive detection of nucleic acids by improving the 
hybridization kinetics of fully matching strands.  
More importantly, the PPT heating was capable to inhibit the spurious binding of non-
matching sequences by elevating the local temperature at the vicinity of AuNIs. SARS-CoV 
and SARS-CoV-2 viruses are similar beta-coronavirus and their genetic similarities are high. 
The specific SARS-CoV-2 genetic target recommended by WHO, i.e. the RdRp-COVID 
sequence as shown in Table S1, is very closely related to that of SARS-CoV. Specifically, in 
the selected gene sequences, only three fixed nucleotide bases were different between RdRp-
COVID and RdRp-SARS. A real-time LSPR detection was conducted on the two closely 
related sequences. The LSPR sensor without the aid of photothermal unit reported a false 
positive response signal when detecting the RdRp-SARS sequence (Figure S7), which 
indicated that a similar but not fully complement sequence was also able to interact and 
partially hybridize with the cDNA receptors at room temperature. Although the hybridization 
kinetics of RdRp-SARS sequence from SARS-CoV was clearly slower than that of SARS-
CoV-2, the non-matching spurious binding of any closely related sequence can affect the 
accurate virus detection and discrimination. Therefore, the local heat based on the proposed 
PPT effect was employed to improve the specificity of hybridization. At the elevated 
temperature of 41 °C as illustrated in Figure 4d, the standard free energy of hybridization was 
weaker due to the mismatched base-pairs. Thus, the similar but not fully matched sequences of 
SARS-CoV can be distinguished. In detail, the calculated association rate constant 𝑘  of 
RdRp-COVID with PPT heating enhancement was found to be 1.11 10  𝑀  𝑠 . The 
detailed discussion and calculation were given in Figure S6c. For a typical biological sensing 
system, 𝑘  ranges between 10  to 10  𝑀  𝑠  and a higher associate rate indicates a stronger 
binding affinity.36, 37 In a comparison experiment including the PPT heat with 32 mW optical 
power, the 532 nm laser was applied onto the surface of the AuNIs sensor from 200 s to 700 s 
as shown in Figure 4e. The local PPT heat was generated immediately to make the LSPR phase 
jump to about 1.76 radian. After turning off the laser at 700 s, the LSPR phase response of the 
mismatching RdRp-SARS gene was fully suppressed to the ground state of blank measurement 
(i.e. the responses from 0 to 200 s) as shown by the black curve in Figure 4e. Since the RdRp-
SARS sequences reported a weak response of 0.002 radian, we determined that its association 
rate constant was lower than 10  𝑀  𝑠  under the PPT heating. At the same time the fully 
matching RdRp-COVID sequence from SARS-CoV-2, showed an apparent phase difference 
before and after the laser excitation (orange curve in Figure 4e). Thus, we believed that a 
similar but not fully matched sequence could be distinguished based on their different binding 
affinity and the PPT heating. 
In another set of verification experiments, the RdRp-SARS genes were initially bound 
to the RdRp-COVID-C receptors at room temperature. Then, the 532 nm laser (32 mW) was 
applied on the AuNIs surface to stimulate the local thermoplasmonic effect. In the real-time 
LSPR sensorgram showed in Figure 4f, we observed the dissociation of the RdRp-SARS genes 
from the RdRp-COVID-C receptors after the temperature rise. The calculated dissociation rate 
constant was 8.287  10-3 s-1 as shown in Figure S8. The dissociation half-life t1/2 which 
indicated the time to dissociate half of the hybridized sequences was 83.3 s. In contrast, the 
complementary sequence of RdRp-COVID showed a much lower dissociation rate constant at 
3.5 10  𝑠  and long dissociation half-life time of 1.97 10  s. These results further 
verified that the thermoplasmonic effect can eliminate the non-matching hybridization quickly 
and promote the selective detection of the target sequence, so as to achieve highly accurate 
nucleic acid detection and virus differentiation. Compared with the conventional plasmonic 
biosensing system, we demonstrated how this proposed dual-functional plasmonic sensing 
system can be the basis of a reliable and easy-to-implement thermoplasmonic biosensing 
technique: it can significantly reduce the false-positive-rate and enhance the reliability in 
genetic diagnosis. 
 
Figure 4. PPT enhancement in LSPR biosensing. (a) Schematic illustration of the hybridization 
of two complementary strands. (b) Real-time hybridization of RdRp-COVID and its cDNA 
sequence (RdRp-COVID-C) with or without the thermoplasmonic enhancement. (c) PPT 
enhancement on RdRp-COVID sequence detection at different concentrations. The error bars 
refer to the standard deviations of LSPR responses after reaching the steady conditions 
following the buffer flushing. (d) Schematic illustration of inhibited hybridization of two 
partially matched sequences. The red-arrows indicated the mismatch bases of RdRp-SARS and 
functionalized cDNA of RdRp-COVID. (e) Discrimination of two similar sequences with PPT 
heat. The laser was applied at 200 s and switched off at 700 s. (f) The RdRp-SARS sequence 
dissociation from the immobilized RdRp-COVID-C sequence. The original phase responses 
(red dots) and the corresponding smoothed means (black curve) were shown. 
 
To quantify the sensing performance, the dual-functional plasmonic detections of 
RdRp-COVID were further investigated over the concentration range from 0.01 pM to 50 µM 
as shown in Figure 5a. The AuNIs sensing system started to attain the saturation condition 
when the concentration of the RdRp-COVID sequence reached 1 µM. In contrast, the low 
RdRp-COVID concentration, i.e. 0.1 pM, only resulted in a weak phase response by 2.90 × 
10−3 radian (Figure 5b), which was close to the system blank measurement of 2.92 × 10−3 
radian. Thus, as illustrated in the sensing calibration curve in Figure 5b, the dual-functional 
LSPR sensing system exhibited a limit of the range from 0.1 pM to 1 µM for detecting 
oligonucleotides, covering seven orders of magnitude. The calibrated regression curve was 
further used to estimate the limit of detection (LoD), which is defined by IUPAC (International 
Union of Pure and Applied Chemistry) as the sum of the blank measures, i.e., 2.92 × 10−3 
radian with the nuclease-free water buffer and triple of its standard deviation (Figure S9). Thus, 
the LoD of the photothermal enhanced LSPR sensing system was found to be (2.92 × 10−3) + 
3 × (3.12 × 10−3) = 0.0123 radian as shown by the dashed line in Figure 5b. Therefore, the 
detectable RdRp-COVID sequence concentration corresponding to the systematic LoD was 
about 0.22 ± 0.08 pM (Figure S9). 200 μL analyte solution at this LoD concentration contained 
about 2.26 × 107 copies of the RdRp-COVID sequence. The actual size of SARS-CoV-2 is 
about 29.9 kilobases in length, which is 1000 times longer than the RdRp-COVID sequence 
used in this study.  Thus, based on the LSPR signal – target size relationship, the estimated 
LoD for detecting the entire RNA strands from SARS-CoV-2 could be approximately 2.26 × 
104 copies.38 A recent study reported the viral loads of SARS-CoV-2 from different respiratory 
trace samples including the throat/nasal swabs and the sputum. Based on these clinical 
specimens collected from 82 infected individuals, the overall viral load soon after onset was 
higher than 1 × 106 copies/mL.39 This indicated that our proposed dual-functional LSPR system 
has the potential for direct analysis of SARS-CoV-2 sequences in respiratory samples. 
 
Figure 5. Evaluation of the dual-functional LSPR biosensor performance on detecting viral 
nucleic acids. (a) The plot of LSPR phase responses versus RdRp-COVID oligos 
concentrations using the PPT enhanced LSPR biosensor. (b) Zoom-in view of the low 
concentration range for LoD identification. (c) Concentrations of various viral oligos measured 
using the dual-functional LSPR biosensors. (d) Detection comparison of single analyte RdRp-
COVID and mixture of multiple sequences. The error bars refer to the standard deviations of 
LSPR responses after reaching the steady conditions following the buffer flushing. 
 
In addition to the RdRp-COVID sequence, we also validated our dual-functional LSPR 
sensing system by performing the selective hybridization detection on several different genome 
sequences from both SARS-CoV-2 and SARS-CoV, i.e. the ORF1ab-COVID sequence and 
the E sequence from SARS-CoV-2, the RdRp-SARS sequence from SARS-CoV. The 
corresponding LSPR phase sensing responses with the in situ PPT enhancement were 
illustrated in Figure 5c. The complementary cDNA sequences, i.e. ORF1ab-COVID-C, E-C, 
and RdRp-SARS-C were functionalized onto the AuNIs chips respectively, for the detection 
of specific viral sequence. Since the physical length and molecular weight were roughly same, 
the hybridization of these target sequences reported a similar LSPR phase response (Figure 
5c). As the concentration increased from 1 pM to 1 nM, the mean LSPR response levels of 
each sequence also climbed in a proportional manner, which further proved the feasibility of 
this dual-functional LSPR sensing system for quantitative analysis of viral nucleic acids. 
Among them, the ORF1ab-COVID sequence produced the strongest responses due to its high 
molecular weight (8715.6 g/mol) and long length (28 bases). While the responses for E 
sequence were slightly lower.  
In clinical diagnosis, the respiratory trace samples after viral lysis and RNA extraction 
may contain multiple nucleic acid sequences from the same viral source of SARS-CoV-2. Thus, 
detecting the accurate concentration of a specific sequence under the interference of multiple 
non-specific sequences was beneficial to demonstrate its potential for real clinical applications. 
In the experiments as shown in Figure 5d, the multi-sequences mixture containing RdRp-
COVID sequences (100 pM), E sequences (100 pM), and ORF1ab-COVID sequences (100 
pM), was prepared to simulate an actual sample after virus lysis. The ORF1ab-COVID and E 
sequences in the mixture showed extreme low spurious binding with the immobilized RdRp-
COVID-C receptors. Compared with the standard detection of 100 pM RdRp-COVID as shown 
in Figure 5d, the calculated recovery rate based on the dual-functional LSPR biosensors was 
found to be 96% in the mixture sample. This experimental result further demonstrated that the 
dual-functional LSPR system with the in situ PPT enhancement can perform accurate detection 
of the target sequence and facilitate the highly accurate SARS-CoV-2 detection.  
 
CONCLUSIONS 
Our developed dual-functional plasmonic system has successfully demonstrated a highly 
sensitive, fast and reliable diagnostic capability for SARS-CoV-2 virus detection. This dual-
functional plasmonic biosensing concept integrated the PPT effect and the LSPR sensing 
transduction on a single cost-effective AuNIs chip. By using two different angles of incidence, 
the plasmonic resonances of PPT and LSPR can be excited at two different wavelengths, which 
significantly enhanced the sensing stability, sensitivity and reliability. With this configuration, 
the LSPR sensing unit attained a real-time and label-free detection of viral sequences including 
RdRp-COVID, ORF1ab-COVID and E genes from SARS-Cov-2. More importantly, the in situ 
PPT enhancement on the AuNIs chips dramatically improved the hybridization kinetics and 
the specificity of nucleic acid detection. Similar sequences such as RdRp genes from SARS-
CoV and SARS-CoV-2 can be accurately discriminated with the in situ PPT enhancement. 
Under the outbreak background of COVID-19, this proposed dual-functional LSPR biosensor 
can provide a reliable and easy-to-implement diagnosis platform to improve the diagnostic 
accuracy in clinical tests and relieve the pressure on PCR-based tests.   
 
MATERIALS AND METHODS 
Materials. All chemicals were purchased from commercial suppliers and used without further 
purification. Nuclease-free water was purchased from ThermoFisher and used as the buffer for 
oligonucleotides dilution and LSPR detection. All selected oligonucleotides, including the 
RdRp-COVID, RdRp-SARS, ORF1ab-COVID, E sequence and their thiol-cDNA receptors, 
including the RdRp-COVID-C, RdRp-SARS-C, ORF1ab-COVID-C, E-C were synthesized 
and provided by Microsynth (Balgach, Switzerland). All AuNIs sensor chips and fluidic 
sensing chambers were cleaned using absolute ethanol followed by rinsing with Milli-Q water 
before testing. 
Synthesis of dual-functional AuNIs chip. The AuNIs sensor chips were synthesized based 
on the self-assembly process of thermal dewetted Au nanofilm. The original magnetron-
sputtered Au nanofilms were optimized in a thickness range from 5.0 nm to 5.2 nm. Then the 
Au nanofilm was thermal annealed at 550 °C for 3 hours. The AuNIs were self-assembled on 
the BK7 glass surface. The visible light absorption of each AuNIs sensor chips was measured 
to retrieve the optimal plasmonic resonance condition.   
Dual-functional LSPR system. In our interferometric LSPR phase sensing system, a white 
light sensing beam was generated by a LED source and subsequently linearly polarized by a 
polarizer (P1). The thin birefringent crystal (BC) added sufficient retardation into the two 
orthogonal components of the linearly polarized light, i.e. the s- and p-components to create 
the spectral interferogram. The BK7 prism was able to couple the incident light into the AuNIs-
dielectric interface at an inclined nominal incident angle of 72° and excited the local 
electromagnetic fields in the vicinity of the AuNIs by the Kretschmann configuration. The 
plasmonic resonance wavelength for LSPR sensing transduction was found to be 580 nm. The 
interferometric spectra were screened by an aperture-iris (I1/I2, Thorlabs) with a hole diameter 
of 0.5 mm and finally recorded by the spectrometer (AvaSpec, Avantes). In addition to this 
plasmonic transducing unit, a high-power 532 nm laser diode (LD, 532 nm peak wavelength, 
DJ532-40 Thorlabs) was used for PPT heating by illuminating the AuNIs chips in the normal 
incident angle. A long-wavelength pass filter (LPF, 552 nm cut-on wavelength) was used to 
block the excitation signal before the spectrometer. The ambient temperature was measured 
and recorded with digital temperature sensors (SHTC1, Sensirion) for LSPR-temperature 
calibration. 
Surface functionalization with thiol-cDNA. The AuNIs surface functionalization was 
investigated based on the step-by-step injection of 0.1nmol thiol-cDNA. In the sensing 
chamber, 90 µL nuclease-free water was initially injected to build the phase reference baseline 
for 400 s. Then, each time a 10 µL solution which contained 0.1 nmol thiol-cDNA, e.g. the 
RdRp-COVID-C sequence was injected into the sensor chamber in every 200 s, until no further 
phase changes were recorded. Based on the optimal result, the solution containing 1nmol 
cDNA was utilized to functionalize the AuNIs chips for the following SARS-CoV-2 sequences 
detection. 
Detection of SARS-CoV-2 viral sequences. After the probe immobilization, the desired 
concentration of target DNA in nuclease-free water (200 μL) was introduced into the AuNIs 
microfluidic chamber for 800 s, and the hybridization reaction was allowed under the PPT heat 
(32 mW optical power at 532 nm). In the LSPR sensing path, an aperture-iris with a hole 
diameter of 0.5 mm was used to screen the sensing beam entering the spectrometer, which 
corresponded to the ATR light from the center of the PPT heat. Experiment on the mismatched 
nucleic acids and multi-sequence mixtures were also conducted based on the dual-functional 
LSPR biosensors as described above. A stringent buffer flushing with nuclease-free water was 
conducted after the hybridization. The whole testing process was real-time recorded by the 
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